Showing results (1261-1270 of 1,560) with videos related to

Sort By:
Pageof 156
BJU International|April 19, 2008
Cluster analysis and lower urinary tract symptoms in men: findings from the Boston Area Community Health SurveyAmy Cinar, Susan A Hall, Carol L Link, et al.
The American Journal of Cardiology|July 1, 1978
Disease of the left main coronary artery. Surgical treatment and long-term follow up in 267 patientsJ B Farinha, M A Kaplan, C N Harris, et al.
The Journal of Urology|July 24, 2012
Prostate biopsy in response to a change in nadir prostate specific antigen of 0.4 ng/ml after treatment with 5α-reductase inhibitors markedly enhances the detection rate of prostate cancerSteven A Kaplan, Richard K Lee, Doreen E Chung, et al.
BJU International|April 19, 2008
Do urological symptoms cluster among women? Results from the Boston Area Community Health SurveySusan A Hall, Amy Cinar, Carol L Link, et al.
Behavioural Processes|April 10, 2022
Applied behavioral economics and public health policies: Historical precedence and translational promiseDerek D Reed, Justin C Strickland, Brett W Gelino, et al.
Urology|February 1, 1996
The Hytrin Community Assessment Trial study: a one-year study of terazosin versus placebo in the treatment of men with symptomatic benign prostatic hyperplasia. HYCAT Investigator GroupC G Roehrborn, J E Oesterling, S Auerbach, et al.
Urology|July 22, 1998
Intermittent alpha-blocker therapy in the treatment of men with lower urinary tract symptomsS A Kaplan, R B Reis, A Cologna, et al.
Analytical and Bioanalytical Chemistry|January 15, 2013
Neuronal metabolomics by ion mobility mass spectrometry: cocaine effects on glucose and selected biogenic amine metabolites in the frontal cortex, striatum, and thalamus of the ratKimberly A Kaplan, Veronica M Chiu, Peter A Lukus, et al.
Lancet (London, England)|February 15, 1986
Growth without growth hormone: evidence for a potent circulating human growth factorM E Geffner, B M Lippe, N Bersch, et al.
Urology|October 12, 2020
Mirabegron Vs Placebo Add-on Therapy in Men With Overactive Bladder Symptoms Receiving Tamsulosin for Underlying Benign Prostatic Hyperplasia: A Safety Analysis From the Randomized, Phase 4 PLUS StudySender Herschorn, Kevin T McVary, Javier Cambronero Santos, et al.
Pageof 156